Standard
Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes. / Wedge, Eileen; Sengeløv, Henrik; Hansen, Jakob Werner; Andersen, Niels Smedegaard; Schjødt, Ida; Petersen, Søren Lykke; Kornblit, Brian; Grønbæk, Kirsten; Friis, Lone Smidstrup.
I:
Biology of Blood and Marrow Transplantation, Bind 26, Nr. 6, 2020, s. 1091-1098.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Wedge, E
, Sengeløv, H, Hansen, JW, Andersen, NS, Schjødt, I, Petersen, SL, Kornblit, B
, Grønbæk, K & Friis, LS 2020, '
Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes',
Biology of Blood and Marrow Transplantation, bind 26, nr. 6, s. 1091-1098.
https://doi.org/10.1016/j.bbmt.2020.02.010APA
Wedge, E.
, Sengeløv, H., Hansen, J. W., Andersen, N. S., Schjødt, I., Petersen, S. L., Kornblit, B.
, Grønbæk, K., & Friis, L. S. (2020).
Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes.
Biology of Blood and Marrow Transplantation,
26(6), 1091-1098.
https://doi.org/10.1016/j.bbmt.2020.02.010Vancouver
Wedge E
, Sengeløv H, Hansen JW, Andersen NS, Schjødt I, Petersen SL o.a.
Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes.
Biology of Blood and Marrow Transplantation. 2020;26(6):1091-1098.
https://doi.org/10.1016/j.bbmt.2020.02.010Author
Wedge, Eileen ; Sengeløv, Henrik ; Hansen, Jakob Werner ; Andersen, Niels Smedegaard ; Schjødt, Ida ; Petersen, Søren Lykke ; Kornblit, Brian ; Grønbæk, Kirsten ; Friis, Lone Smidstrup. / Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes. I: Biology of Blood and Marrow Transplantation. 2020 ; Bind 26, Nr. 6. s. 1091-1098.
Bibtex
@article{f26aed1ac15849ceb156b2b0eaa45d8c,
title = "Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes",
author = "Eileen Wedge and Henrik Sengel{\o}v and Hansen, {Jakob Werner} and Andersen, {Niels Smedegaard} and Ida Schj{\o}dt and Petersen, {S{\o}ren Lykke} and Brian Kornblit and Kirsten Gr{\o}nb{\ae}k and Friis, {Lone Smidstrup}",
year = "2020",
doi = "10.1016/j.bbmt.2020.02.010",
language = "English",
volume = "26",
pages = "1091--1098",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier",
number = "6",
}
RIS
TY - JOUR
T1 - Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes
AU - Wedge, Eileen
AU - Sengeløv, Henrik
AU - Hansen, Jakob Werner
AU - Andersen, Niels Smedegaard
AU - Schjødt, Ida
AU - Petersen, Søren Lykke
AU - Kornblit, Brian
AU - Grønbæk, Kirsten
AU - Friis, Lone Smidstrup
PY - 2020
Y1 - 2020
U2 - 10.1016/j.bbmt.2020.02.010
DO - 10.1016/j.bbmt.2020.02.010
M3 - Journal article
C2 - 32088368
VL - 26
SP - 1091
EP - 1098
JO - Biology of Blood and Marrow Transplantation
JF - Biology of Blood and Marrow Transplantation
SN - 1083-8791
IS - 6
ER -
